Jennifer Backo

Director, US Advertising & Promotion, Regulatory Affairs at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jennifer Backo's Colleagues at Alnylam Pharmaceuticals
Taryn Catlin

Director, Early Stage Quality

Contact Taryn Catlin

Gerard Walsh

Director Supply Chain Technical Services

Contact Gerard Walsh

Andrew Hagger

Manager, Process Engineering

Contact Andrew Hagger

Gautham Sridharan

Principal Scientist, Research

Contact Gautham Sridharan

Brian Nasipak

Associate Director, Forecasting and Analytics

Contact Brian Nasipak

Paul Miller

Senior Director, Regulatory Technology, Operations & Filing Excellence

Contact Paul Miller

View All Jennifer Backo's Colleagues
Jennifer Backo's Contact Details
HQ
(617) 551-8200
Location
Lexington, Massachusetts, United States
Company
Alnylam Pharmaceuticals
Jennifer Backo's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jennifer Backo
Jennifer Backo currently works for Alnylam Pharmaceuticals.
Jennifer Backo's role at Alnylam Pharmaceuticals is Director, US Advertising & Promotion, Regulatory Affairs.
Jennifer Backo's email address is ***@alnylam.com. To view Jennifer Backo's full email address, please signup to ConnectPlex.
Jennifer Backo works in the SaaS industry.
Jennifer Backo's colleagues at Alnylam Pharmaceuticals are Taryn Catlin, Gerard Walsh, Andrew Hagger, Gautham Sridharan, Brian Nasipak, Raymond Ortega, Paul Miller and others.
Jennifer Backo's phone number is (617) 551-8200
See more information about Jennifer Backo